CXCR2 and lung carcinoma: Senescent cancer cells promoted CXCR2 expression and mediated the resistance against therapy, meanwhile, inhibition of CXCR2 was found to promote cancer cell senescence process, then improved the survival period of patients with Head-and-Neck and lung carcinoma [22, 23].